ICD-10-CM Billable Code

H02.88

Meibomian gland dysfunction of eyelid

Clinical Classification Guidelines

Medical Intelligence & Overview

Meibomian gland dysfunction (MGD) is a common condition affecting the tiny oil-producing glands located in the eyelids. These glands are responsible for secreting oils that form a vital part of the tear film, which helps keep the eyes lubricated and protect them from infections. When these glands become blocked or their secretions become abnormal, it can lead to a range of eye discomfort and other ocular issues. ICD-10 code H02.88 specifically captures cases of Meibomian gland dysfunction of the eyelid, highlighting its significance within ophthalmic health concerns.

Causes & Symptoms

Clinical Causes: Blockage of the Meibomian glands due to thickened or altered secretions Inflammation of the eyelids, such as blepharitis Hormonal changes, especially in women during menopause Age-related gland drop-out or degeneration Skin conditions like rosacea Environmental factors like prolonged screen use, exposure to wind or smoke Use of certain cosmetic eyelid products or medications Chronic eyelid hygiene issues

Key Symptoms: Oily or greasy-looking eyelid margins Crusty eyelid edges, especially in the mornings Irritation and redness of the eyes A sensation of dryness or grit in the eyes Itching along the eyelid margins Watery eyes or excessive tearing Blurred vision that improves with blinking Sensitivity to light Frequent eyelid inflammation

Diagnostic & Treatment

Diagnosis Path: Diagnosis of Meibomian gland dysfunction typically involves a comprehensive eye examination. An ophthalmologist or optometrist will assess the eyelids for signs of gland blockage, inflammation, and abnormal secretions. Special procedures may include expressing the glands to analyze the quality and quantity of the secretions. Additional tests might include eyelid imaging or meibography to visualize gland structure and assess gland loss or atrophy. Patient history regarding symptoms and eyelid hygiene habits will also inform the diagnosis.

Treatment Protocols: Warm compresses applied to eyelids to soften gland secretions and promote drainage Eyelid hygiene with gentle cleaning to reduce inflammation and crusting Massaging the eyelids to express the glands manually Use of artificial tears or lubricating eye drops to relieve dryness Light-based therapies such as intense pulsed light (IPL) to reduce inflammation and gland blockage Topical or oral medications, including antibiotics like doxycycline, for its anti-inflammatory effects Lifestyle modifications, such as reducing screen time and managing environmental exposures In some cases, eyelid scrubs or medications prescribed by an eye care specialist may be recommended for persistent cases

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is H02.88 a billable ICD-10 code?
Yes, H02.88 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report H02.88?
Clinical documentation must specify the nature of Meibomian gland dysfunction of eyelid and any associated comorbidities for accurate reporting.

Cite this Clinical Reference